EichorEICHOR
Study identifier: NCT06524414 Synced from ClinicalTrials.gov · August 04, 2026
● Active Not Recruiting

A Study to Learn About How a New Pneumococcal Vaccine Works in Infants

Condition: Pneumococcal Disease  ·  Sponsor: Pfizer

PhasePhase 2
Planned participants605
Who can joinAll sexes, 42 Days to 98 Days
Healthy volunteersYes

About this study

The purpose of this study is to learn about the safety of a new pneumococcal vaccine and how the new pneumococcal vaccine helps to fight against germs in infants when compared to the pneumococcal vaccines that are currently in use, 20vPnC (Prevnar 20®) or another licensed pneumococcal vaccine. To ensure that the new vaccine (PG4) stays stable, it is placed in a liquid mixture of sterile water and other substances (a solution). This study will also test if there is a difference in the safety and immune effects of the new pneumococcal vaccine when it is one type of solution compared to when it is in a different type of solution. The immune response is how the body's cells; tissues and organs work together to protect the body from infection. Blood samples will be used to measure the amount of antibodies produced after the vaccination. Antibodies are proteins that protect you when an unwanted germ enters the body. This will help understand how well the new pneumococcal vaccine works. This vaccine can possibly provide protection against pneumococcal disease. Pneumococcal disease includes a variety of infections caused by a specific germ, Streptococcus pneumoniae. This study is seeking participants who are: * male or female infants who are 2 months of age, * infants born at 36 weeks (about 8 and a half months) of pregnancy or later; and, * said to be healthy by the study doctor There are four groups in this study. All participants will be assigned to one of the four groups. Al…

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (68)

Northwest Arkansas Pediatric ClinicFayetteville, Arkansas, United States
The Children's ClinicJonesboro, Arkansas, United States
Los Ninos Children's Medical ClinicLa Puente, California, United States
Los Ninos Children's Medical ClinicWest Covina, California, United States
Velocity Clinical Research, Washington DCWashington D.C., District of Columbia, United States
Riveldi Biomedical Research and Associates - MiamiMiami Lakes, Florida, United States
Clinical Research PrimeIdaho Falls, Idaho, United States
The Iowa ClinicAnkeny, Iowa, United States
Cotton O'Neil PediatricsTopeka, Kansas, United States
Kentucky Pediatric/ Adult ResearchBardstown, Kentucky, United States
All Children PediatricsLouisville, Kentucky, United States
Bluegrass Clinical Research, Inc.Louisville, Kentucky, United States

+ 56 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →